TO: |
RNS |
FROM: |
BMO Managed Portfolio Trust PLC |
DATE: |
25 January 2022 |
LEI: |
213800ZA6TW45NM9YY31 |
|
|
Unaudited Interim Results
The Board of BMO Managed Portfolio Trust PLC announces the unaudited interim results of the Company for the six month period to 30 November 2021.
Income Shares - Financial Highlights and Performance Summary for the Six Months
· Dividend yield(1) of 4.3% at 30 November 2021, compared to the yield on the FTSE All-Share Index of 3.2%. Dividends are paid quarterly and this year the aim is to make the payments of more equal amounts.
· Net asset value total return(1) per Income share of +1.7% for the six months underperforming the FTSE All-Share Index total return of +1.9% by -0.2%.
Growth Shares - Financial Highlights and Performance Summary for the Six Months
· Net asset value total return(1) per Growth share of +5.0% for the six months outperforming the FTSE All-Share Index total return of +1.9% by +3.1%.
· The net asset value per Growth share has increased by +214.0% over 10 years, the equivalent of +12.1% compound(1) per year. This has outperformed the FTSE All-Share Index total return of +103.0%, the equivalent of +7.3% compound per year.
Notes:
(1) Yield, total return and compound annual growth rate - See Alternative Performance Measures.
Chairman's Statement
Highlights
· Net asset value ("NAV") total return for the six months of +1.7% for the Income shares and +5.0% for the Growth shares as compared to the FTSE All-Share Index total return of +1.9%
· NAV total return compound annual growth rate over 10 years of +9.4% for the Income shares and +12.1% for the Growth shares compared with +7.3% from the FTSE All-Share Index
· Income share dividend yield of 4.3% at 30 November 2021
Investment Performance
For the six months to 30 November 2021, the NAV total return was +1.7% for the Income shares and +5.0% for the Growth shares. The total return for the benchmark index for both share classes, the FTSE All-Share Index, was +1.9%. The long-term track record continues to show the NAV total return for both share classes outperforming the benchmark index over 3 years, 5 years and 10 years to 30 November 2021, with the NAV total return over 10 years achieving a compound annual growth rate of +9.4% for the Income shares and +12.1% for the Growth shares compared with +7.3% from the benchmark index.
The period under review experienced a reversal of the trend that had been evident in financial markets since the announcement of the first vaccines for COVID-19 in November 2020. Equity markets, sectors and individual stocks that had been perceived to benefit from a re-opening of economies had recovered strongly. However, from the beginning of June 2021 this changed, and bond yields, which had been rising in anticipation of very robust economic growth, began to subside. Growth, though still strong, was less than expected. The UK equity market which had been one of the best performers amongst global markets began to lag, and sectors and stocks previously leading the recovery also started to underperform on a relative basis and stocks that had done well earlier in the pandemic resumed their trend of outperformance. These were led by the US technology sector; as an illustration the Nasdaq Composite Index gained 21.8% over the period.
This trend benefitted the Growth Portfolio, which outperformed the benchmark index over the
six months to 30 November 2021. A number of investment companies with exposure to the wider technology sector were the leading performers. This was led by the portfolio's largest holding Allianz Technology Trust which gained 30%. This was closely followed by HgCapital Trust ('HGT') which rose 27%. HGT is a private equity trust that specialises in business-critical software companies mainly based in Europe. Over the year to 30 September 2021, their top 20 holdings which account for over 80% of the assets of the trust grew earnings at 29% and revenues at 25%. The next best performer was another long-time holding, Scottish Mortgage Investment Trust, which experienced a 25% rise in its share price mainly as a result of its technology and healthcare holdings.
Due to the requirement for yield, it is always a challenge for the Income Portfolio to gain exposure to the secular growth opportunities offered by investment companies investing in the technology sector where the underlying companies pay no or low dividends. This was the main reason why the Income Portfolio was slightly behind the benchmark index over the six months to 30 November 2021. The leading performer and the largest holding was NB Private Equity Partners ('NBPE') whose share price gained 33%. NBPE is managed in the US where the majority of its portfolio is located. Most of its holdings are co-investments with other well known private equity managers like Blackstone and KKR. Recently its largest holding Autostore, which provides warehouse robot technology solutions for customers worldwide, was successfully listed on the Oslo Stock Exchange. NBPE pays a dividend equivalent to 3% of its NAV annually. The next best performer with a 14% rise in its share price was 3i Infrastructure. This has been one of the best performers in the Income Portfolio over the long term and also increased its dividend by 7% in its recent interim results.
(All share prices are total return).
Revenue and Dividends
The Company's net revenue return for the six months was £1.67 million which is equivalent to 3.54p per Income share (compared to 3.57p per Income share for the corresponding period in 2020). Income shareholders are entitled to all the dividends paid by the Company. One benefit of the closed-end investment trust structure is the ability to utilise revenue reserves, built up in previous years, to sustain dividend payments during periods when there is a significant reduction in dividend income from underlying holdings. That has been the case over the course of the COVID-19 pandemic and enabled many of our holdings to sustain or, in some cases, grow their dividend payments. Over recent months a number of holdings in the Income Portfolio have begun to announce increased dividend payments which is an encouraging sign of a return to health after the worst effects of the pandemic.
With the aim of making the quarterly interim dividends of more equal amounts, the rate for each of the first and second interim dividends in respect of the year to 31 May 2022 was increased to 1.55p per Income share (1.4p per Income share in the corresponding periods in the year to 31 May 2021).
In the absence of unforeseen circumstances, the Board intends to pay three quarterly interim dividends, each of 1.55p per Income share, and that the aggregate dividends for the current financial year to 31 May 2022 will be at least 6.2p per Income share (2021: 6.2p per Income share). As a result of making the interim dividends of more equal amounts and the increase in each of the first two interim dividends and the anticipated increase in the third interim dividend, the fourth interim dividend is expected to be lower than last year. The amount of the fourth interim dividend will be determined when a clearer view emerges of income for the year. A minimum expected annual rate of 6.2p per Income share represents a yield on the Income share price at 30 November 2021 of 4.3% which is materially higher than the yield of 3.2% on the FTSE All-Share Index at the same date.
Borrowing
At 30 November 2021 the Income Portfolio had total borrowings of £7 million (9.4% of gross assets), the investment of which helps to boost net income after allowing for the interest cost. The Growth Portfolio had no borrowings.
Management of Share Premium and Discount to NAV
In normal circumstances we aim to maintain the discount to NAV at which our shares trade at not more than 5%. In practice over the years the shares have generally traded close to NAV. During the six months to 30 November 2021 the average premium to NAV for the Income shares and for the Growth shares was 1.0% and 0.7% respectively. At 30 November 2021, the Income shares stood at a premium to NAV of 2.1% and the Growth shares at a premium of 1.4% to NAV.
Share Conversion Facility
Shareholders have the opportunity to convert their Income shares into Growth shares or their Growth shares into Income shares annually subject to minimum and maximum conversion thresholds which may be reduced or increased at the discretion of the Board. On 4 November 2021 the conversion proceeded for those shareholders who had elected to do so. The net result of those conversions was a decrease of 27,625 Income shares and an increase of 13,595 Growth shares in issue. The ability to convert without incurring capital gains tax should be an attractive facility for shareholders and the next conversion date (subject to minimum and maximum thresholds) will be in October 2022. Details will be provided when the Company's annual report is published in late July 2022.
Board Changes
Following the Annual General Meeting on 30 September 2021, the Chairman Colin McGill retired from the Board and I was pleased to accept the Board's invitation to become Chairman. Colin was a director of your Company for over 13 years since its launch in 2008 and served as Chairman of the Audit Committee until January 2019 at which point he was appointed Chairman of the Board. I would like to thank Colin for his exceptional contribution and commitment to the Company throughout this time.
Following Colin's retirement I have also become Chairman of the Management Engagement Committee and Nomination Committee. As noted in the last Annual Report, David Harris was also appointed as a director at the launch of the Company in 2008 and has now served on the Board for close to 14 years. It is anticipated that David will retire at the AGM in September 2022 and a recruitment process to identify a new non-executive director will be undertaken in the first half of 2022.
Ownership of the Manager
On 8 November 2021, Columbia Threadneedle Investments, part of Ameriprise Financial, acquired BMO's EMEA asset management business ('BMO GAM (EMEA)'). This added £97 billion of assets under management ('AUM') to Columbia Threadneedle increasing its AUM to £530 billion. This was a transaction that was discussed in the Chairman's Statement in respect of the year to 31 May 2021. Your Board maintained a regular dialogue with BMO and has met with the CEO of Columbia Threadneedle Investments. We look forward to benefitting from the increase in scale and resources that the combined BMO/Columbia Threadneedle business can provide, and we are assured there will be no changes to the personnel running the activities of your Company in terms of both Fund Management and Administration.
Outlook
As Governments and Central Banks acknowledge that inflation has moved from being "transitory" to "sustained", this has reflected in a tapering down of monetary stimulus and the start (albeit from very low levels) of increases in interest rates. The Bank of England increased UK rates in December. The key theme in 2022 will be the speed and magnitude of interest rate rises and the chances of a policy mistake have increased.
For equity markets, volatility will likely increase and against a background of higher inflation and rising interest rates, positive equity returns may be harder to achieve. One of the features of the past decade has been the superior level of corporate earnings growth in the US, almost entirely due to the technology sector. In particular, the Growth Portfolio has benefitted from a number of investment companies with significant exposure in this area. Although earnings growth will remain strong from the US, the high valuations accorded to many companies in the technology sector may come under pressure in an environment when inflation is higher and interest rates start to rise. As economies continue to recover, the ability to grow earnings may not be so scarce and investors may begin to question the extent of the valuation premium of "growth" companies. At a market level this favours non-US equities, with European stock markets well placed, as is the UK stock market which is the most lowly valued.
In terms of investment strategy, the aim is to continue increasing exposure to UK equity trusts, especially those with a medium and smaller company bias, and also certain trusts with a decent exposure to Europe. This would be funded by some reduction in investment companies with significant exposure to technology and/or high growth companies.
David Warnock
Chairman
24 January 2022
Unaudited Condensed Income Statement
Six months to 30 November 2021
|
|
| |||
|
|
|
|
| |
| Notes | Revenue | Capital | Total | |
|
| £'000 | £'000 | £'000 | |
Gains on investments |
| - | 5,364 | 5,364 | |
Foreign exchange losses |
| - | (2) | (2) | |
Income | 2 | 2,178 | - | 2,178 | |
Investment management and performance fees | 3 | (171) | (675) | (846) | |
Other expenses |
| (307) | - | (307) | |
Return on ordinary activities before finance costs and tax |
|
1,700 |
4,687 |
6,387 | |
Finance costs |
| (28) | (42) | (70) | |
Return on ordinary activities before tax |
| 1,672 | 4,645 | 6,317 | |
Tax on ordinary activities |
| - | - | - | |
Return attributable to shareholders |
| 1,672 | 4,645 | 6,317 | |
Return per Income share (pence) | 4 | 3.54p | (1.23p) | 2.31p | |
Return per Growth share (pence) | 4 | - | 13.75p | 13.75p | |
|
|
|
|
| |
The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.
All revenue and capital items in the Income Statement derive from continuing operations.
Return attributable to shareholders represents the profit/(loss) for the period and also total comprehensive income.
Unaudited Condensed Income Statement
Six months to 30 November 2020
| Notes | Revenue | Capital | Total |
|
| £'000 | £'000 | £'000 |
Gains on investments |
| - | 20,873 | 20,873 |
Foreign exchange losses |
| - | (13) | (13) |
Income | 2 | 2,109 | - | 2,109 |
Investment management and performance fees | 3 | (138) | (619) | (757) |
Other expenses |
| (281) | - | (281) |
Return on ordinary activities before finance costs and tax |
|
1,690 |
20,241 |
21,931 |
Finance costs |
| (22) | (33) | (55) |
Return on ordinary activities before tax |
| 1,668 | 20,208 | 21,876 |
Tax on ordinary activities |
| - | - | - |
Return attributable to shareholders |
| 1,668 | 20,208 | 21,876 |
Return per Income share (pence) | 4 | 3.57p | 11.12p | 14.69p |
Return per Growth share (pence) | 4 | - | 41.58p | 41.58p |
The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.
All revenue and capital items in the Income Statement derive from continuing operations.
Return attributable to shareholders represents the profit/(loss) for the period and also total comprehensive income.
Condensed Income Statement (audited)
Year to 31 May 2021
|
|
| |||
|
|
|
|
| |
| Notes | Revenue | Capital | Total | |
|
| £'000 | £'000 | £'000 | |
|
|
|
|
| |
Gains on investments |
| - | 38,132 | 38,132 | |
Foreign exchange losses |
| - | (17) | (17) | |
Income | 2 | 4,022 | - | 4,022 | |
Investment management and performance fees | 3 | (290) | (1,360) | (1,650) | |
Other expenses |
| (589) | - | (589) | |
Return on ordinary activities before finance costs and tax |
|
3,143 |
36,755 |
39,898
| |
Finance costs |
| (47) | (69) | (116) | |
|
|
|
|
| |
Return on ordinary activities before tax |
| 3,096 | 36,686 | 39,782 | |
Tax on ordinary activities |
| (16) | - | (16) | |
Return attributable to shareholders |
| 3,080 | 36,686 | 39,766 | |
Return per Income share (pence) | 4 | 6.59p | 25.94p | 32.53p | |
Return per Growth share (pence) | 4 | - | 67.27p | 67.27p | |
The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.
All revenue and capital items in the Income Statement derive from continuing activities.
Return attributable to shareholders represents the profit/(loss) for the year and also total comprehensive income.
Unaudited Condensed Balance Sheet
As at 30 November 2021
|
|
| ||
| Notes | Income Shares | Growth Shares |
Total |
|
| £'000 | £'000 | £'000 |
Fixed assets |
|
|
|
|
Listed investments | 6 | 72,215 | 105,604 | 177,819 |
|
|
|
|
|
Current assets |
|
|
|
|
Debtors |
| 380 | 63 | 443 |
Cash at bank and on deposit |
| 2,053 | 5,847 | 7,900 |
|
|
|
|
|
|
| 2,433 | 5,910 | 8,343 |
|
|
|
|
|
Creditors: Amounts falling due within one year |
7 |
(7,230) |
(996) |
(8,226) |
|
|
|
|
|
Net current (liabilities)/assets |
| (4,797) | 4,914 | 117 |
|
|
|
|
|
Creditors: Amounts falling due in more than one year |
|
- |
- |
- |
|
|
|
|
|
Net assets |
| 67,418 | 110,518 | 177,936 |
|
|
|
|
|
Capital and reserves: |
|
|
|
|
Called-up share capital | 8 | 4,540 | 3,622 | 8,162 |
Share premium |
| 28,793 | 27,594 | 56,387 |
Capital redemption reserve |
| 256 | 365 | 621 |
Special reserve |
| 18,980 | 17,199 | 36,179 |
Capital reserves |
| 11,794 | 61,738 | 73,532 |
Revenue reserve |
| 3,055 | - | 3,055 |
|
|
|
|
|
Shareholders' funds |
| 67,418 | 110,518 | 117,936 |
|
|
|
|
|
Net asset value per share (pence) | 9 | 141.07p | 289.81p |
|
Unaudited Condensed Balance Sheet
As at 30 November 2020
| Notes | Income Shares | Growth Shares |
Total |
|
| £'000 | £'000 | £'000 |
Fixed assets |
|
|
|
|
Listed investments |
| 63,466 | 88,159 | 151,625 |
|
|
|
|
|
Current assets |
|
|
|
|
Debtors |
| 230 | 77 | 307 |
Cash at bank and on deposit |
| 1,237 | 3,127 | 4,364 |
|
|
|
|
|
|
| 1,467 | 3,204 | 4,671 |
|
|
|
|
|
Creditors: Amounts falling due within one year |
7 |
(491) |
(393) |
(884) |
|
|
|
|
|
Net current assets |
| 976 | 2,811 | 3,787 |
|
|
|
|
|
Creditors: Amounts falling due in more than one year |
|
(5,000) |
- |
(5,000) |
|
|
|
|
|
Net assets |
| 59,442 | 90,970 | 150,412 |
|
|
|
|
|
Capital and reserves: |
|
|
|
|
Called-up share capital |
| 4,446 | 3,458 | 7,904 |
Share premium |
| 27,359 | 23,019 | 50,378 |
Capital redemption reserve |
| 252 | 364 | 616 |
Special reserve |
| 18,990 | 17,162 | 36,152 |
Capital reserves |
| 5,442 | 46,967 | 52,409 |
Revenue reserve |
| 2,953 | - | 2,953 |
|
|
|
|
|
Shareholders' funds |
| 59,442 | 90,970 | 150,412 |
|
|
|
|
|
Net asset value per share (pence) | 9 | 127.16p | 249.94p |
|
Condensed Balance Sheet (audited)
As at 31 May 2021
| Notes | Income shares | Growth shares |
Total |
| £'000 | £'000 | £'000 | |
|
|
|
|
|
Fixed assets |
|
|
|
|
Listed investments | 6 | 72,121 | 101,052 | 173,173 |
Current assets |
|
|
|
|
Debtors |
| 272 | 54 | 326 |
Cash at bank and on deposit |
| 2,040 | 3,769 | 5,809 |
|
|
|
|
|
|
| 2,312 | 3,823 | 6,135 |
Creditors |
|
|
|
|
Amounts falling due within one year | 7 | (7,667) | (649) | (8,316) |
|
|
|
|
|
Net current (liabilities)/assets |
| (5,355) | 3,174 | (2,181) |
|
|
|
|
|
Creditors: |
|
|
|
|
Amounts falling due in more than one year |
| - | - | - |
|
|
|
|
|
Net assets |
| 66,766 | 104,226 | 170,992 |
|
|
|
|
|
Capital and reserves |
|
|
|
|
Called-up share capital | 8 | 4,459 | 3,586 | 8,045 |
Share premium |
| 27,608 | 26,599 | 54,207 |
Capital redemption reserve |
| 256 | 365 | 621 |
Special reserve |
| 19,017 | 17,162 | 36,179 |
Capital reserves |
| 12,373 | 56,514 | 68,887 |
Revenue reserve |
| 3,053 | - | 3,053 |
|
|
|
|
|
Shareholders' Funds |
| 66,766 | 104,226 | 170,992 |
|
|
|
|
|
Net asset value per share (pence) | 9 | 142.22p | 276.01p |
|
Unaudited Condensed Statement of Cash Flows
Six months to 30 November 2021
| Notes | Income shares | Growth shares |
Total |
|
| £'000 | £'000 | £'000 |
|
|
|
|
|
Net cash outflow from operations before dividends and interest |
10 |
(841) |
(921) |
(1,762) |
Dividends received |
| 1,540 | 573 | 2,113 |
Interest received |
| - | - | - |
Interest paid |
| (59) | - | (59) |
Net cash inflow/(outflow) from operating activities |
| 640 | (348) | 292 |
Investing activities |
|
|
|
|
Purchases of investments |
| (1,620) | (2,120) | (3,740) |
Sales of investments |
| 1,506 | 3,478 | 4,984 |
Cash flows from investing activities |
| (114) | 1,358 | 1,244 |
Cash flows before financing activities |
| 526 | 1,010 | 1,536 |
Financing activities |
|
|
|
|
Equity dividends paid Net proceeds from issuance of new shares | 5 | (1,670) 1,196 | - 1,029 | (1,670) 2,225 |
Share conversion |
| (39) | 39 | - |
Cash flows from financing activities |
| (513) | 1,068 | 555 |
Net movement in cash and cash equivalents |
| 13 | 2,078 | 2,091 |
Cash and cash equivalents at the beginning of the period |
|
2,040 |
3,769 |
5,809 |
Cash and cash equivalents at the end of the period |
|
2,053 |
5,847 |
7,900 |
Represented by: Cash at bank and short-term deposits |
|
2,053 |
5,847 |
7,900 |
Unaudited Condensed Statement of Cash Flows
Six months to 30 November 2020
| Notes | Income shares | Growth shares |
Total |
|
| £'000 | £'000 | £'000 |
|
|
|
|
|
Net cash outflow from operations before dividends and interest |
10 |
(277) |
(942) |
(1,219) |
Dividends received |
| 1,519 | 531 | 2,050 |
Interest received |
| - | - | - |
Interest paid |
| (52) | - | (52) |
Net cash inflow/(outflow) from operating activities |
| 1,190 | (411) | 779 |
Investing activities |
|
|
|
|
Purchases of investments |
| (1,327) | (2,777) | (4,104) |
Sales of investments |
| 1,529 | 2,053 | 3,582 |
Cash flows from investing activities |
| 202 | (724) | (522) |
Cash flows before financing activities |
| 1,392 | (1,135) | 257 |
Financing activities |
|
|
|
|
Equity dividends paid Net proceeds from issuance of new shares | 5 | (1,540) 488 | - 1,056 | (1,540) 1,544 |
Shares purchased to be held in treasury |
| (29) | - | (29) |
Share conversion |
| (135) | 135 | - |
Cash flows from financing activities |
| (1,216) | 1,191 | (25) |
Net movement in cash and cash equivalents |
| 176 | 56 | 232 |
Cash and cash equivalents at the beginning of the period |
|
1,061 |
3,071 |
4,132 |
Cash and cash equivalents at the end of the period |
|
1,237 |
3,127 |
4,364 |
Represented by: Cash at bank and short-term deposits |
|
1,237 |
3,127 |
4,364 |
Condensed Statement of Cash Flows (audited)
Year to 31 May 2021
|
Notes | Income shares | Growth shares |
Total | |
|
| £'000 | £'000 | £'000 | |
|
|
|
|
| |
Net cash outflow from operations before dividends and interest |
10 |
(606) |
(1,413) |
(2,019) | |
Dividends received |
| 2,891 | 1,072 | 3,963 | |
Interest received |
| 1 | - | 1 | |
Interest paid |
| (118) | - | (118) | |
Net cash inflow/(outflow) from operating activities |
| 2,168 | (341) | 1,827 | |
Investing activities |
|
|
|
| |
Purchases of investments |
| (4,363) | (8,174) | (12,537) | |
Sales of investments |
| 3,409 | 4,313 | 7,722 | |
Cash flows from investing activities |
| (954) | (3,861) | (4,815) | |
Cash flows before financing activities |
| 1,214 | (4,202) | (2,988) | |
Financing activities |
|
|
|
| |
Equity dividends paid | 5 | (2,852) | - | (2,852) | |
Net proceeds from issue of new shares Sale of shares from treasury |
| 710 599 | 4,765 - | 5,475 599 | |
Shares purchased to be held in treasury |
| (557) | - | (557) | |
Share conversion |
| (135) | 135 | - | |
Loan drawn down |
| 2,000 | - | 2,000 | |
Cash flows from financing activities |
| (235) | 4,900 | 4,665 | |
Net movement in cash and cash equivalents |
| 979 | 698 | 1,677 | |
Cash and cash equivalents at the beginning of the year |
|
1,061 |
3,071 |
4,132 | |
Cash and cash equivalents at the end of the year |
|
2,040 |
3,769 |
5,809 | |
Represented by: Cash at bank and short-term deposits |
|
2,040 |
3,769 |
5,809 | |
Unaudited Condensed Statement of Changes in Equity
Six months to 30 November 2021
Income shares |
Share capital £000 | Share premium account £000 | Capital redemption reserve £000 |
Special reserve £000 |
Capital reserves £000 |
Revenue reserve £000 | Total shareholders' funds £000 |
As at 31 May 2021 | 4,459 | 27,608 | 256 | 19,017 | 12,373 | 3,053 | 66,766 |
Increase in share capital in issue, net of share issuance expenses |
83 |
1,185 |
- |
- |
- |
- |
1,268 |
Share conversion | (2) | - | - | (37) | - | - | (39) |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
327 |
327 |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
(327) |
- |
(327) |
Dividends paid | - | - | - | - | - | (1,670) | (1,670) |
Return attributable to shareholders |
- |
- |
- |
- |
(252) |
1,345 |
1,093 |
As at 30 November 2021 |
4,540 |
28,793 |
256 |
18,980 |
11,794 |
3,055 |
67,418 |
|
|
|
|
|
|
|
|
Growth shares |
|
|
|
|
|
|
|
As at 31 May 2021 | 3,586 | 26,599 | 365 | 17,162 | 56,514 | - | 104,226 |
Increase in share capital in issue, net of issuance expenses |
34 |
995 |
- |
- |
- |
- |
1,029 |
Share conversion | 2 | - | - | 37 | - | - | 39 |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
(327) |
(327) |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
327 |
- |
327 |
Return attributable to shareholders |
- |
- |
- |
- |
4,897 |
327 |
5,224 |
As at 30 November 2021 |
3,622 |
27,594 |
365 |
17,199 |
61,738 |
- |
110,518 |
Total |
|
|
|
|
|
|
|
As at 31 May 2021 | 8,045 | 54,207 | 621 | 36,179 | 68,887 | 3,053 | 170,992 |
Increase in share capital in issue, net of share issuance expenses |
117 |
2,180 |
- |
- |
- |
- |
2,297 |
Share conversion | - | - | - | - | - | - | - |
Dividends paid | - | - | - | - | - | (1,670) | (1,670) |
Return attributable to shareholders |
- |
- |
- |
- |
4,645 |
1,672 |
6,317 |
Total Company as at 30 November 2021 |
8,162 |
56,387 |
621 |
36,179 |
73,532 |
3,055 |
177,936 |
Unaudited CondensedStatement of Changes in Equity
Six months to 30 November 2020
Income shares |
Share capital £000 | Share premium account £000 | Capital redemption reserve £000 |
Special reserve £000 |
Capital reserves £000 |
Revenue reserve £000 | Total shareholders' funds £000 |
As at 31 May 2020 | 4,415 | 26,909 | 252 | 19,147 | 240 | 2,825 | 53,788 |
Increase in share capital in issue, net of share issuance expenses |
38 |
450 |
- |
- |
- |
- |
488 |
Shares purchased for treasury |
- |
- |
- |
(29) |
- |
- |
(29) |
Share conversion | (7) | - | - | (128) | - | - | (135) |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
310 |
310 |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
(310) |
- |
(310) |
Dividends paid | - | - | - | - | - | (1,540) | (1,540) |
Return attributable to shareholders |
- |
- |
- |
- |
5,512 |
1,358 |
6,870 |
As at 30 November 2020 |
4,446 |
27,359 |
252 |
18,990 |
5,442 |
2,953 |
59,442 |
|
|
|
|
|
|
|
|
Growth shares |
|
|
|
|
|
|
|
As at 31 May 2020 | 3,408 | 22,006 | 364 | 17,034 | 31,961 | - | 74,773 |
Increase in share capital in issue, net of issuance expenses |
43 |
1,013 |
- |
- |
- |
- |
1,056 |
Share conversion | 7 | - | - | 128 | - | - | 135 |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
(310) |
(310) |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
310 |
- |
310 |
Return attributable to shareholders |
- |
- |
- |
- |
14,696 |
310 |
15,006 |
As at 30 November 2020 |
3,458 |
23,019 |
364 |
17,162 |
46,967 |
- |
90,970 |
Total |
|
|
|
|
|
|
|
As at 31 May 2020 | 7,823 | 48,915 | 616 | 36,181 | 32,201 | 2,825 | 128,561 |
Increase in share capital in issue, net of share issuance expenses |
81 |
1,463 |
- |
- |
- |
- |
1,544 |
Shares purchased for treasury |
- |
- |
- |
(29) |
- |
- |
(29) |
Share conversion | - | - | - | - | - | - | - |
Dividends paid | - | - | - | - | - | (1,540) | (1,540) |
Return attributable to shareholders |
- |
- |
- |
- |
20,208 |
1,668 |
21,876 |
Total Company as at 30 November 2020 |
7,904 |
50,378 |
616 |
36,152 |
52,409 |
2,953 |
150,412 |
CondensedStatement of Changes in Equity (audited)
Year to 31 May 2021
Income Shares |
Share capital £000 | Share premium account £000 | Capital redemption reserve £000 |
Special reserve £000 |
Capital reserves £000 |
Revenue reserve £000 | Total shareholders' funds £000 |
As at 31 May 2020 | 4,415 | 26,909 | 252 | 19,147 | 240 | 2,825 | 53,788 |
Increase in share capital in issue, net of share issuance expenses |
55 |
655 |
- |
- |
- |
- |
710 |
Shares sold from treasury | - | 44 | - | 555 | - | - | 599 |
Shares purchased for treasury |
- |
- |
- |
(557) |
- |
- |
(557) |
Share conversion | (7) | - | - | (128) | - | - | (135) |
Cancellation of deferred shares |
(4) |
- |
4 |
- |
- |
- |
- |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
564 |
564 |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
(564) |
- |
(564) |
Dividends paid | - | - | - | - | - | (2,852) | (2,852) |
Return attributable to shareholders |
- |
- |
- |
- |
12,697 |
2,516 |
15,213 |
As at 31 May 2021 | 4,459 | 27,608 | 256 | 19,017 | 12,373 | 3,053 | 66,766 |
Growth Shares |
|
|
|
|
|
|
|
As at 31 May 2020 | 3,408 | 22,006 | 364 | 17,034 | 31,961 | - | 74,773 |
Increase in share capital in issue, net of share issuance expenses |
172 |
4,593 |
- |
- |
- |
- |
4,765 |
Share conversion | 7 | - | - | 128 | - | - | 135 |
Cancellation of deferred shares |
(1) |
- |
1 |
- |
- |
- |
- |
Transfer of net income from Growth to Income portfolio |
- |
- |
- |
- |
- |
(564) |
(564) |
Transfer of capital from Income to Growth portfolio |
- |
- |
- |
- |
564 |
- |
564 |
Return attributable to shareholders | - | - | - | - | 23,989 | 564 | 24,553 |
As at 31 May 2021 | 3,586 | 26,599 | 365 | 17,162 | 56,514 | - | 104,226 |
Total |
|
|
|
|
|
|
|
As at 31 May 2020 | 7,823 | 48,915 | 616 | 36,181 | 32,201 | 2,825 | 128,561 |
Increase in share capital in issue, net of share issuance expenses |
227 |
5,248 |
- |
- |
- |
- |
5,475 |
Shares sold from treasury |
- |
44 |
- |
555 |
- |
- |
599 |
Shares purchased for treasury |
- |
- |
- |
(557) |
- |
- |
(557) |
Share conversion | - | - | - | - | - | - | - |
Cancellation of deferred shares |
(5) |
- |
5 |
- |
- |
- |
- |
Dividends paid | - | - | - | - | - | (2,852) | (2,852) |
Return attributable to shareholders |
- |
- |
- |
- |
36,686 |
3,080 |
39,766 |
Total Company as at 31 May 2021 |
8,045 |
54,207 |
621 |
36,179 |
68,887 |
3,053 |
170,992 |
Notes
1. Accounting policies
These condensed financial statements, which are unaudited, have been prepared on a going concern basis in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, FRS 102, FRS 104 Interim Financial Reporting and the Statement of Recommended Practice ("SORP") "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by The Association of Investment Companies ("AIC").
The accounting policies applied for the condensed financial statements are set out in the Company's annual report for the year ended 31 May 2021.
2. Income
| Six months to 30 November 2021 | Six months to 30 November 2020 | Year to 31 May 2021 |
| £'000 | £'000 | £'000 |
UK dividends | 1,738 | 1,579 | 2,772 |
Overseas dividends | 440 | 530 | 1,249 |
Deposit income | - | - | 1 |
Total income | 2,178 | 2,109 | 4,022 |
3. Investment management and performance fees
| Six months to 30 November 2021 | Six months to 30 November 2020 | Year to 31 May 2021 |
| £'000 | £'000 | £'000 |
Investment management fee | 609 | 483 | 1,025 |
Performance fee | 237 | 274 | 625 |
| 846 | 757 | 1,650 |
At 30 November 2021 the adjusted total return of the Income portfolio for the period since 31 May 2021 (being the date a performance fee was last payable and including the outperformance brought forward in excess of the cap of 0.35% of total assets at 31 May 2021) exceeded that of the FTSE All-Share Index and a performance fee of £42,000 was accrued in the Income portfolio (30 November 2020: £114,000; 31 May 2021: £259,000).
At 30 November 2021 the adjusted total return of the Growth portfolio for the period since 31 May 2021 (being the date a performance fee was last payable and including the outperformance brought forward in excess of the cap of 0.35% of total assets at 31 May 2021) exceeded that of the FTSE All-Share Index and a performance fee of £1,473,000 has been calculated (30 November 2020: £1,695,000; 31 May 2021: £1,471,000). However, as the performance fee is capped at 0.35% of total assets of the relevant portfolio, the fee has been scaled back, in line with the cap, and an amount of £195,000 (30 November 2020: £160,000; 31 May 2021: £366,000) has been recognised.
4. Return per share
The return per share for the six months to 30 November 2021 is as follows:
| Income shares | Growth shares | ||||
| Revenue | Capital | Total | Revenue | Capital | Total |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
Return attributable to portfolios |
1,345 |
(252) |
1,093 |
327 |
4,897 |
5,224 |
Transfer of net income from Growth to Income portfolio |
327 |
- |
327 |
(327) |
- |
(327) |
Transfer of capital from Income to Growth portfolio |
- |
(327) |
(327) |
- |
327 |
327 |
Return attributable to shareholders |
1,672 |
(579) |
1,093 |
- |
5,224 |
5,224 |
Return per share | 3.54p | (1.23p) | 2.31p | - | 13.75p | 13.75p |
Weighted average number of shares in issue during the period |
47,256,712 |
37,999,706 |
The return per share for the comparative six months to 30 November 2020 is as follows:
| Income shares | Growth shares | ||||
| Revenue | Capital | Total | Revenue | Capital | Total |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
Return attributable to portfolios |
1,358 |
5,512 |
6,870 |
310 |
14,696 |
15,006 |
Transfer of net income from Growth to Income portfolio |
310 |
- |
310 |
(310) |
- |
(310) |
Transfer of capital from Income to Growth portfolio |
- |
(310) |
(310) |
- |
310 |
310 |
Return attributable to shareholders |
1,668 |
5,202 |
6,870 |
- |
15,006 |
15,006 |
Return per share | 3.57p | 11.12p | 14.69p | - | 41.58p | 41.58p |
Weighted average number of shares in issue during the period |
46,766,360 |
36,089,942 |
The return per share for the comparative year to 31 May 2021 is as follows:
| Income shares | Growth shares | ||||
| Revenue | Capital | Total | Revenue | Capital | Total |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
Return attributable to portfolios |
2,516 |
12,697 |
15,213 |
564 |
23,989 |
24,553 |
Transfer of net income from Growth to Income portfolio |
564 |
- |
564 |
(564) |
- |
(564) |
Transfer of capital from Income to Growth portfolio |
- |
(564) |
(564) |
- |
564 |
564 |
Return attributable to shareholders |
3,080 |
12,133 |
15,213 |
- |
24,553 |
24,553 |
Return per share | 6.59p | 25.94p | 32.53p | - | 67.27p | 67.27p |
Weighted average number of shares in issue during the period |
46,772,385 |
36,497,458 |
5. Dividends
|
Payment | Six months to 30 November 2021 | Six months to 30 November 2020 | Year to 31 May 2021 |
Dividends on Income shares | Date | £'000 | £'000 | £'000 |
Amounts recognised as distributions during the period: |
|
|
|
|
In respect of the previous financial year: |
|
|
|
|
- fourth interim of 2.0p (prior period: 1.9p) per share |
9-Jul-2021 |
939 |
883 |
883 |
In respect of the period under review: |
|
|
|
|
- first interim of 1.55p (prior period: 1.4p) per share |
8-Oct-2021 |
731 |
657 |
657 |
- second interim (prior period: 1.4p per share) |
- |
- |
- |
655 |
- third interim (prior period: 1.4p per share) |
- |
- |
- |
657 |
|
| 1,670 | 1,540 | 2,852 |
A second interim dividend in respect of the year to 31 May 2022 of 1.55p per Income share was paid on 7 January 2022 to shareholders on the register on 17 December 2021. This amount has not been accrued in the results for the six months to 30 November 2021.
For the financial year to 31 May 2021 interim dividends totalled 6.2p per Income share.
The Growth shares do not carry an entitlement to receive dividends.
6. Investments
| Income shares Level 1* £'000 | Growth shares Level 1* £'000 |
Total £'000 |
Cost at 31 May 2021 Gains at 31 May 2021 | 52,669 19,452 | 51,601 49,451 | 104,270 68,903 |
Valuation at 31 May 2021 Movement in the period: Purchases at cost Sales proceeds (Losses)/gains on investments sold in the period Gains on investments held at period end | 72,121
1,618 (1,506) (252) 234 | 101,052
2,648 (3,478) 1,942 3,440 | 173,173
4,266 (4,984) 1,690 3,674 |
Valuation of investments held at 30 November 2021 |
72,215 |
105,604 |
177,819 |
| Income shares Level 1* £'000 | Growth shares Level 1* £'000 |
Total £'000 |
Cost at 30 November 2021 Gains at 30 November 2021 | 52,529 19,686 | 52,713 52,891 | 105,242 72,577 |
Valuation at 30 November 2021 | 72,215 | 105,604 | 177,819 |
* Fair value hierarchy
Total (losses)/gains on investments | Income shares £'000 | Growth shares £'000 |
Total £'000 |
(Losses)/gains on investments sold in the period Gains on investments held at period end | (252) 234 | 1,942 3,440 | 1,690 3,674 |
Total (losses)/gains on investments | (18) | 5,382 | 5,364 |
The Company's Investments as disclosed in the balance sheet are valued at fair value. The fair value as at the reporting date has been estimated using the following fair value hierachy:
· Level 1 - quoted prices (unadjusted) in active markets for identical assets;
· Level 2 - investments whose value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets; and
· Level 3 - investments whose value is not based on observable market data.
There were no investments held which are valued in accordance with Levels 2 or 3.
7. Creditors
Amounts falling due within one year
30 November 2021 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 | |
£5 million fixed rate term loan maturing 10 February 2022 |
5,000 |
- |
5,000 | |
Revolving credit facility | 2,000 | - | 2,000 | |
Management fee accrued | 124 | 182 | 306 | |
Performance fee provision | 42 | 195 | 237 | |
Secretarial fee accrued | 10 | 16 | 26 | |
Amount due to brokers | - | 528 | 528 | |
Other accruals | 54 | 75 | 129 | |
| 7,230 | 996 | 8,226 | |
30 November 2020 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 |
Management fee accrued | 105 | 145 | 250 |
Performance fee provision | 320 | 160 | 480 |
Secretarial fee accrued | 11 | 15 | 26 |
Other accruals | 55 | 73 | 128 |
| 491 | 393 | 884 |
31 May 2021 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 |
£5 million fixed rate term loan maturing 10 February 2022 |
5,000 |
- |
5,000 |
Revolving credit facility | 2,000 | - | 2,000 |
Management fee accrued | 119 | 169 | 288 |
Performance fee accrued | 465 | 366 | 831 |
Secretarial fee accrued | 10 | 15 | 25 |
Other accruals | 73 | 99 | 172 |
| 7,667 | 649 | 8,316 |
The Company has a £5 million unsecured fixed rate term loan and a £5 million unsecured revolving credit facility with The Royal Bank of Scotland International Limited. The fixed rate term loan and the unsecured revolving credit facility are available until 10 February 2022. £5 million of the fixed rate term loan was drawn down as at 30 November 2021 (30 November 2020: £5 million; 31 May 2021: £5 million) and the interest rate on the amount drawn down is fixed at 2.03% per annum. £2 million of the unsecured revolving credit facility was drawn down as at 30 November 2021 (30 November 2020: nil; 31 May 2021: £2 million). The interest rate on the amounts drawn down are variable, and a non-utilisation fee is payable on undrawn amounts.
During the six months to 30 November 2021 there were no changes in the amount borrowed and therefore no change in liabilities arising from financing activities.
8. Share capital
| Listed | Held in treasury | In issue | |||
| Number | £'000 | Number | £'000 | Number | £'000 |
Income shares |
|
|
|
|
|
|
Balance at 1 June 2021^ |
46,944,790 |
4,459 |
- |
- |
46,944,790 |
4,459 |
Issued | 875,000 | 83 | - | - | 875,000 | 83 |
Share conversion: |
|
|
|
|
|
|
- Income to Growth | (150,027) | (15) | - | - | (150,027) | (15) |
- Growth to Income | 122,402 | 12 | - | - | 122,402 | 12 |
Balance at 30 November 2021^ | 47,792,165 | 4,539 | - | - | 47,792,165 | 4,539 |
| Deferred shares - Income |
|
| |||
| Number | £'000 |
|
|
|
|
Deferred shares - Income |
|
|
|
|
|
|
Balance at 1 June 2021 | - | - |
|
|
|
|
Issue of 150,027 shares* | 150,027 | 1 |
|
|
|
|
Balance at 30 November 2021 | 150,027 | 1 |
|
|
|
|
Total called-up share capital |
| 4,540 |
|
|
|
|
^ The nominal value of each Income share is £0.094976101 per Income share.
* The nominal value of a Deferred share is £0.006337311 per share.
During the period, the Company issued 875,000 Income shares (30 November 2020: 400,000; 31 May 2021: 575,000) from the block listing facilities receiving net proceeds of £1,268,000
(30 November 2020: £488,000; 31 May 2021: £710,000).
During the period, valid conversion notices were received to convert 150,027 Income shares (which represented a value of £212,000). These were converted into 73,833 Growth shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.
The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2021 AGM.
| Listed | Held in treasury | In issue | |||
| Number | £'000 | Number | £'000 | Number | £'000 |
Growth shares |
|
|
|
|
|
|
Balance at 1 June 2021^ | 37,761,553 | 3,586 | - | - | 37,761,553 | 3,586 |
Issued | 360,000 | 34 | - | - | 360,000 | 34 |
Share conversion: |
|
|
|
|
|
|
- Growth to Income | (60,238) | (5) | - | - | (60,238) | (5) |
- Income to Growth | 73,833 | 7 | - | - | 73,833 | 7 |
Balance at 30 November 2021^ |
38,135,148 |
3,622 |
- |
- |
38,135,148 |
3,622 |
| Deferred shares - |
|
| |||
|
| Growth |
|
|
|
|
| Number | £'000 |
|
|
|
|
Deferred shares - Growth |
|
|
|
|
|
|
Balance at 1 June 2021 | - | - |
|
|
|
|
Issue of 60,238 shares* | 60,238 | - |
|
|
|
|
Balance at 30 November 2021 | 60,238 | - |
|
|
|
|
Total called-up share capital |
| 3,622 |
|
|
|
|
^ The nominal value of each Growth share is £0.094976101 per Growth share.
* The nominal value of a Deferred share is £0.006337311 per share.
During the period, the Company issued 360,000 Growth shares (30 November 2020: 450,000; 31 May 2021: 1,815,000) from the block listing facilities receiving net proceeds of £1,029,000
(30 November 2020: £1,056,000; 31 May 2021: £4,765,000).
During the period, valid conversions were received to convert 60,238 Growth shares (which represented a value of £173,000). These were converted into 122,402 Income shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.
The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2021 AGM.
9. Net asset value per share
| 30 November 2021 | 30 November 2020 | 31 May 2021 |
Income shares |
|
|
|
Net asset value per share - pence | 141.07p | 127.16p | 142.22p |
Net assets attributable at end of period - £'000 |
67,418 |
59,442 |
66,766 |
Shares in issue at end of period - number | 47,792,165 | 46,744,790 | 46,944,790 |
|
|
|
|
Growth shares |
|
|
|
Net asset value per share - pence | 289.81p | 249.94p | 276.01p |
Net assets attributable at end of period - £'000 |
110,518 |
90,970 |
104,226 |
Shares in issue at end of period - number | 38,135,148 | 36,396,553 | 37,761,553 |
10. Reconciliation of return on ordinary activities before tax to net cash flows from operating activities
Six months to 30 November 2021 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 | |
Return on ordinary activities before tax Adjust for returns from non-operating activities: | 1,093
| 5,224 | 6,317 | |
Losses/(gains) on investments | 18 | (5,382) | (5,364) | |
Exchange losses | 2 | - | 2 | |
Return from operating activities | 1,113 | (158) | 955 | |
Decrease in prepayments | 2 | 8 | 10 | |
Decrease in creditors | (437) | (181) | (618) | |
Withholding tax recovered | (1) | - | (1) | |
Dividend income | (1,588) | (590) | (2,178) | |
Interest expense | 70 | - | 70 | |
Net cash outflow from operations before dividends and interest |
(841) |
(921) |
(1,762) | |
Six months to 30 November 2020 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 | |
Return on ordinary activities before tax Adjust for returns from non-operating activities: | 6,870
| 15,006 | 21,876 | |
Gains on investments | (5,794) | (15,079) | (20,873) | |
Exchange losses | 13 | - | 13 | |
Return from operating activities | 1,089 | (73) | 1,016 | |
Decrease in prepayments | 5 | 5 | 10 | |
Increase/(decrease) in creditors | 112 | (340) | (228) | |
Withholding tax recovered | 37 | - | 37 | |
Dividend income | (1,575) | (534) | (2,109) | |
Interest expense | 55 | - | 55 | |
Net cash outflow from operations before dividends and interest |
(277) |
(942) |
(1,219) | |
Year to 31 May 2021 |
Income shares £'000 |
Growth shares £'000 |
Total £'000 | |
Return on ordinary activities before tax Adjust for returns from non-operating activities: | 15,229
| 24,553 | 39,782 | |
Gains on investments | (13,297) | (24,835) | (38,132) | |
Exchange losses | 17 | - | 17 | |
Return from operating activities | 1,949 | (282) | 1,667 | |
Decrease/(increase) in prepayments | 2 | (7) | (5) | |
Increase/(decrease) in creditors | 288 | (84) | 204 | |
Withholding tax recovered | 21 | - | 21 | |
Dividend income | (2,981) | (1,040) | (4,021) | |
Interest income | (1) | - | (1) | |
Interest expense | 116 | - | 116 | |
Net cash outflow from operations before dividends and interest |
(606) |
(1,413) |
(2,019) | |
11. Earnings
Earnings for the six months to 30 November 2021 should not be taken as a guide to the results for the full year to 31 May 2022.
12. Tax
The effective revenue tax rate for the period to 30 November 2021 is nil% (30 November 2020: nil%; 31 May 2021: 0.5%). This is lower than the rate of corporation tax for small companies due to the level of non-taxable dividend income.
13. Going concern
In assessing the going concern basis of accounting, the Directors have had regard to the guidance issued by the Financial Reporting Council (including that related to COVID-19) and have undertaken a rigorous review of the Company's ability to continue as a going concern and specifically in the context of the COVID-19 pandemic.
The Company's investment objective and policy, which is subject to regular Board monitoring processes, is designed to ensure that the Company is invested principally in listed securities. The value of these investments exceeds the Company's liabilities by a significant margin.
The Company retains title to all assets held by its custodian and has agreements relating to its borrowing facilities with which it has complied. Cash is only held with banks approved and regularly reviewed by the Manager.
The Directors believe, having assessed the principal risks and other matters, including the COVID-19 pandemic and in light of the controls and review processes and bearing in mind the nature of the Company's business and assets and revenue and expenditure projections, that the Company has adequate resources to continue in operational existence within its stated investment policy for a period of at least twelve months commencing from the date of approval of the financial statements. Accordingly, the financial statements have been drawn up on the basis that the Company is a going concern.
The Company does not have a fixed life. However, the Company's Articles of Association require the Board to put a resolution to shareholders at every fifth AGM to continue the Company. An ordinary resolution to approve the continuation of the Company was passed at the AGM held on 19 September 2018 and will next be put to shareholders at the AGM in 2023.
14. Related party transactions
The Directors of the Company are considered a related party. There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or performance of the Company during the period and there have been no changes in the related party transactions described in the last Annual Report that could do so.
15. Results
The Company's auditor, KPMG LLP, has not audited or reviewed the Interim Report to 30 November 2021 pursuant to the Auditing Practices Board guidance on 'Review of Interim Financial Information'. These are not full statutory financial statements in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory financial statements for the year ended 31 May 2021, which received an unqualified audit report, and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. The abridged financial statements included for the year ended 31 May 2021 are an extract from those financial statements. No full statutory financial statements in respect of any period after 31 May 2021 have been reported on by the Company's auditor or delivered to the Registrar of Companies.
The Interim Report to 30 November 2021 is available on the website maintained on behalf of the Company at www.bmomanagedportfolio.com
Statement of Principal Risks and Uncertainties
Most of the Company's principal risks and uncertainties that could threaten the achievement of its objective, strategy, future performance, liquidity and solvency are market related and comparable to those of other investment trusts investing primarily in listed securities.
These risks, and the way in which they are managed, are described in more detail under the heading ''Principal Risks and Uncertainties and Viability Statement" within the Strategic Report in the Company's Annual Report for the year ended 31 May 2021. The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the remainder of the Company's financial year.
The principal risks identified in the Annual Report were:
· Market Risk. The Company's assets consist mainly of listed closed-end investment companies and its principal financial risks are therefore market related and include market risk (comprising currency risk, interest rate risk and other price risk), liquidity risk and credit risk
· Investment Risk
· Custody Risk
· Operational Risk
These include risks in relation to failures at service providers or loss or sabotage of data through
cyber attacks or business continuity failure.
The Board has also considered the impact of the COVID-19 pandemic which has increased uncertainty and volatility in markets and has impacted the value of investments. In addition the operational resilience of the Manager and the Company's other third party service providers has been considered. This is included within market risk and operational risk.
Statement of Directors' Responsibilities in Respect of the Interim Report
We confirm, that to the best of our knowledge:
· the condensed set of financial statements have been prepared in accordance with applicable UK Accounting Standards on a going concern basis and give a true and fair view of the assets, liabilities, financial position and return of the Company;
· the Chairman's Statement and the Statement of Principal Risks and Uncertainties (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure Guidance and Transparency Rule ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;
· the Statement of Principal Risks and Uncertainties is a fair review of the principal risks and uncertainties for the remainder of the financial year; and
· the Interim Report includes a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.
On behalf of the Board
David Warnock
Director
24 January 2022
Alternative Performance Measures ("APMs")
The Company uses the following APMs:
Discount/premium - the share price of an investment company is derived from buyers and sellers trading their shares on the stock market. This price is not identical to the net asset value (NAV) per share of the underlying assets less liabilities of the Company. If the share price is lower than the NAV per share, the shares are trading at a discount. This usually indicates that there are more sellers of shares than buyers. Shares trading at a price above NAV per share are deemed to be at a premium usually indicating there are more buyers of shares than sellers.
|
| 30 November 2021 | 31 May 2021 | ||
|
| Income shares | Growth shares | Income shares | Growth shares |
|
|
|
|
|
|
Net asset value per share | (a) | 141.07p | 289.81p | 142.22p | 276.01p |
Share price | (b) | 144.00p | 294.00p | 143.50p | 277.00p |
Premium (c=(b-a)/(a)) |
(c) |
+2.1% |
+1.4% |
+0.9% |
+0.4% |
Total return - the return to shareholders calculated on a per share basis taking into account both any dividends paid in the period to the increase or decrease in the share price or NAV in the period. The dividends are assumed to have been re-invested in the form of shares or net assets, respectively, on the date on which the shares were quoted ex-dividend.
The effect of reinvesting these dividends on the respective ex-dividend dates and the share price total returns and NAV total returns are shown below.
| Six months to | Year to | ||
| 30 November 2021 | 31 May 2021 | ||
| Income shares | Growth shares | Income shares | Growth shares |
|
|
|
|
|
NAV per share at start of financial period/year |
142.22p |
276.01p |
115.71p |
208.35p |
NAV per share at end of financial period/year |
141.07p |
289.81p |
142.22p |
276.01p |
Change in the period/year | -0.8% | +5.0% | +22.9% | +32.5% |
Impact of dividend reinvestment (1) | 2.5% | n/a | 6.1% | n/a |
NAV total return for the period/year | +1.7% | +5.0% | +29.0% | +32.5% |
(1) During the six months to 30 November 2021 dividends totalling 3.55p went ex-dividend with respect to the Income shares. During the year to 31 May 2021 the equivalent figure was 6.2p.
| Six months to 30 November 2021 | Year to 31 May 2021 | ||
| Income shares | Growth shares | Income shares | Growth shares |
|
|
|
|
|
|
|
|
|
|
Share price per share at start of financial period/year |
143.5p |
277.0p |
117.5p |
212.0p |
Share price per share at end of financial period/year |
144.0p |
294.0p |
143.5p |
277.0p |
Change in the period/year | +0.3% | +6.1% | +22.1% | +30.7% |
Impact of dividend reinvestment (1) | 2.5% | n/a | 6.1% | n/a |
Share price total return for the period/year |
+2.8% |
+6.1% |
+28.2% |
+30.7% |
(1) During the six months to 30 November 2021 dividends totalling 3.55p went ex-dividend with respect to the Income shares. During the year to 31 May 2021 the equivalent figure was 6.2p.
Yield - the total annual dividend expressed as a percentage of the period-end share price.
|
| 30 November 2021 | 31 May 2021 |
Annual dividend | (a) | 6.2p(1) | 6.2p |
Income share price | (b) | 144.0p | 143.5p |
Yield (c=a/b) | (c) | 4.3% | 4.3% |
(1) Based on dividends at the expected minimum annual rate of 6.20 pence per Income share for the
financial year to 31 May 2022.
Net gearing/net cash - this is the ratio of the borrowings of the Company to its net assets. If the Company has cash assets, these may be assumed to net off against borrowings giving a "net" gearing percentage. Where cash assets exceed borrowings, the Company is described as having "net cash".
| 30 November 2021 | 31 May 2021 | ||
| Income shares | Growth shares | Income shares | Growth shares |
| £'000 | £'000 | £'000 | £'000 |
|
|
|
|
|
Borrowing | (7,000) | - | (7,000) | - |
Cash | 2,053 | 5,847 | 2,040 | 3,769 |
| (4,947) | 5,847 | (4,960) | 3,769 |
Net assets | 67,418 | 110,518 | 66,766 | 104,226 |
-Net gearing/ +net cash |
-7.3% |
+5.3% |
-7.4% |
+3.6% |
Compound annual growth rate - converts the total return over a period of more than one year to a constant annual rate of return applied to the compounded value at the start of each year.
30 November 2021 | |||
|
| Income shares | Growth shares |
Indexed NAV total return at 30 November 2011 |
| 100.0 | 100.0 |
Indexed NAV total return at 30 November 2021 |
| 245.5 | 314.0 |
Period (years) |
| 10.0 | 10.0 |
Compound annual growth rate |
| 9.4% | 12.1% |
For further information, please contact:
Peter Hewitt, BMO Investment Business Limited 0131 718 1244
Ian Ridge, BMO Investment Business Limited 0131 718 1010